Therefore, more data is needed to determine whether tirzepatide or retatrutide is the more potent weight loss agent
By replicating the close surveillance seen in clinical trials through connected scales, automated alerts, and structured protocols, we can help more patients lose weight safely, adhere to their treatment plan, and avoid preventable complications
East Asia, particularly China and Japan, is expected to be the key growth region with growth rates of 15.4% and 12.0%, respectively
Natural therapies for weight loss have been a hot topic especially with the increasing use of GLP-1 agonists such as semaglutide (Ozempic/Wegovy) for weight management
[DOI] [PMC free article] [PubMed] [Google Scholar] 91.Cava E., Yeat N.C., Mittendorfer B